FIELD: medicine.
SUBSTANCE: method involves administering granulocytic colony formation stimulating factor. The remedy is subcutaneously injected at a dose of 125 mg/kg once a day during 1-5 days. Encephalopathy is modeled with hypoxia or intraperitoneal injection phenylhydrazine chloride.
EFFECT: enhanced effectiveness of treatment; prevented erythropoiesis precursor cell injuries.
3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CORRECTING AFFECTED ERYTHROPOIESIS AT EXPERIMENTAL HYPOXIA | 2005 |
|
RU2285300C1 |
METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
METHOD OF DETERMINING EFFICACY OF HAEMOSTIMULATORS IN CYTOSTATIC MYELOSUPPRESSION | 2009 |
|
RU2421720C2 |
METHOD FOR CARRYING OUT EXPERIMENTAL ENCEPHALOPATHY THERAPY | 2004 |
|
RU2284060C1 |
METHOD FOR PREPARING CELL TRANSPLANTATION MATERIAL IN MYELOSUPPRESSION | 2008 |
|
RU2392947C1 |
MEDICATION PREVENTING DEVELOPMENT OF DEPRESSION OF HEMATOPOIESIS ERYTHROID LINEAGE IN CASE OF CYTOSTATIC MYELO DEPRESSIONS | 2007 |
|
RU2351333C1 |
METHOD FOR TREATING EXPERIMENTAL CHRONIC TOXIC HEPATITIS | 2005 |
|
RU2295971C1 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
TREATMENT METHOD FOR HEMATOPOIETIC ERYTHROID LINEAGE DEPRESSION IN CYTOSTATIC MYELOSUPRESSION | 2008 |
|
RU2364398C1 |
MEDICAL PRODUCTS FOR ANEMIA PREVENTION AND TREATMENT WITHIN NEUROTIC AFFECTS | 2006 |
|
RU2329035C1 |
Authors
Dates
2007-07-10—Published
2005-09-28—Filed